Hikal Limited — Updates, 27-05-2026: Press Release
27-05-2026 | 04:49 pm
27-05-2026 | 04:49 pm
Hikal's Q4 revenue was ₹ 519 Cr, PAT ₹ 14 Cr, impacted by ₹ 47 Cr asset impairment. Pharma and Crop Protection saw strong H2 recovery, with new segments advancing. Board approved a 20% final dividend for investors.
No comments yet. Be the first to comment!
